IL3RA and cancer: Since TEC in TNBC expresses IL-3Rα and TEC targeted by the anti-IL-3Rα antibody release paracrine signals that induce vessel regression31, we hypothesize that IL-3Rα blockade on TEC, via EVs, would be effective in driving dynamic changes in tumors/TME interfering with cancer progression.